--- title: "Hormel Foods (HRL) to report Q4 2024 earnings results, a look at what to expect" type: "News" locale: "en" url: "https://longbridge.com/en/news/221046056.md" description: "Hormel Foods Corporation (NYSE: HRL) is set to report its Q4 2024 earnings on December 4. The company’s shares rose over 1% recently, with a 5% gain over the past month. Analysts project Q4 revenue at $2.14 billion, down over 1% year-over-year. The expected earnings per share is $0.42, matching last year's Q4. Hormel anticipates growth in key retail brands and the Foodservice segment, despite challenges in certain areas. The International business is also expected to improve, particularly in China and Southeast Asia." datetime: "2024-11-29T16:26:35.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/221046056.md) - [en](https://longbridge.com/en/news/221046056.md) - [zh-HK](https://longbridge.com/zh-HK/news/221046056.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/221046056.md) | [繁體中文](https://longbridge.com/zh-HK/news/221046056.md) # Hormel Foods (HRL) to report Q4 2024 earnings results, a look at what to expect Shares of Hormel Foods Corporation (NYSE: HRL) rose over 1% on Friday. The stock has gained over 5% in the past one month. The branded food company is slated to report its fourth quarter 2024 earnings results on Wednesday, December 4, before market open. Here’s a look at what to expect: ## **Revenue** Analysts are projecting revenue of $3.14 billion for Hormel in Q4 2024. This represents a drop of over 1% from the same period last year. In the third quarter of 2024, net sales decreased 2% year-over-year to $2.90 billion. ## **Earnings** The consensus estimate for earnings per share in Q4 2024 is $0.42. This compares to adjusted EPS of $0.42 reported in the fourth quarter of 2023 and $0.37 reported in the third quarter of 2024. ## **Points to note** In the fourth quarter, Hormel is expected to benefit from continued demand for many of its key retail brands such as _Hormel Black Label_ bacon, _Applegate_ meats, _Jennie-O_ ground turkey, and _Skippy_ peanut butter. The company has been doing well in categories like bacon, canned meats, turkey and peanut butter. It has also been seeing a stabilization in its convenient meals and proteins business. In Q3, the Retail segment results were negatively impacted by volume and price declines for whole bird turkeys, lower sales of _Planters_ snack nuts caused by production disruptions at the Suffolk facility, and lower contract manufacturing volumes. The company expects to see improved service levels for the _Planters_ snack nuts business in the fourth quarter but the contract manufacturing business is anticipated to see continued softness due to low demand for certain items. The Foodservice business is expected to deliver growth in Q4. Last quarter, sales and volume in this segment benefited from strong performance across the turkey, premium prepared proteins, bacon and pepperoni categories. Products such as Old Smokehouse Bacon, Café H proteins, and Jennie-O turkey delivered double-digit sales growth. Hormel’s portfolio and the diverse channels it operates in continued to provide its Foodservice business a cushion against several macro headwinds. Hormel expects to see growth in its International business during the fourth quarter. Despite a drop in sales and volume last quarter, the company saw improvement in its performance versus the previous year. This segment benefited from gains in SPAM luncheon meat, Skippy peanut butter, and refrigerated foodservice exports. Its China business appears to be on a positive trajectory and its investments in the Philippines and Indonesia are beginning to pay off. The post Hormel Foods (HRL) to report Q4 2024 earnings results, a look at what to expect first appeared on AlphaStreet. ### Related Stocks - [Hormel Foods Corporation (HRL.US)](https://longbridge.com/en/quote/HRL.US.md) ## Related News & Research - [SunOpta (STKL) Reports Q4: Everything You Need To Know Ahead Of Earnings](https://longbridge.com/en/news/280947019.md) - [NHS clears Wegovy to reduce risk of heart attack and stroke](https://longbridge.com/en/news/281323250.md) - [Short Interest in Nomad Foods Limited (NYSE:NOMD) Declines By 17.0%](https://longbridge.com/en/news/280986886.md) - [Why Jetro deal makes Sysco stock a great long-term pick](https://longbridge.com/en/news/281035693.md) - [Precigen Details Papzimeos Commercial Launch, Hub Growth and J-Code Catalyst at H.C. Wainwright Chat](https://longbridge.com/en/news/281233412.md)